BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 23972941)

  • 21. Anemia and Red Blood Cell Indices Predict HIV-Associated Neurocognitive Impairment in the Highly Active Antiretroviral Therapy Era.
    Kallianpur AR; Wang Q; Jia P; Hulgan T; Zhao Z; Letendre SL; Ellis RJ; Heaton RK; Franklin DR; Barnholtz-Sloan J; Collier AC; Marra CM; Clifford DB; Gelman BB; McArthur JC; Morgello S; Simpson DM; McCutchan JA; Grant I;
    J Infect Dis; 2016 Apr; 213(7):1065-73. PubMed ID: 26690344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlates of the HIV-associated neurocognitive disorders among adults living with HIV in Dodoma region, central Tanzania: A cross-sectional study.
    Nyundo AA
    PLoS One; 2023; 18(5):e0285761. PubMed ID: 37228133
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients.
    Ciccarelli N; Fabbiani M; Di Giambenedetto S; Fanti I; Baldonero E; Bracciale L; Tamburrini E; Cauda R; De Luca A; Silveri MC
    Neurology; 2011 Apr; 76(16):1403-9. PubMed ID: 21502598
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurocognitive impairment in treatment-experienced adults living with HIV attending primary care clinics in Zimbabwe.
    Nyamayaro P; Gouse H; Hakim J; Robbins RN; Chibanda D
    BMC Infect Dis; 2020 May; 20(1):383. PubMed ID: 32471350
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurocognitive Disorders in HIV-positive Patients.
    Padole PS; Padhiyar RN; Yadav DS; Chavan SA
    J Assoc Physicians India; 2023 Jun; 71(6):11-12. PubMed ID: 37355842
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence and 1-year incidence of HIV-associated neurocognitive disorder (HAND) in adults aged ≥50 years attending standard HIV clinical care in Kilimanjaro, Tanzania.
    Flatt A; Gentry T; Kellett-Wright J; Eaton P; Joseph M; Urasa S; Howlett W; Dekker M; Kisoli A; Rogathe J; Henderson L; Lewis T; Thornton J; McCartney J; Yarwood V; Irwin C; Mukaetova-Ladinska EB; Akinyemi R; Gray WK; Walker RW; Dotchin CL; Quaker AS; Makupa PC; Paddick SM
    Int Psychogeriatr; 2023 Jul; 35(7):339-350. PubMed ID: 33757616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methamphetamine use and neuropsychiatric factors are associated with antiretroviral non-adherence.
    Moore DJ; Blackstone K; Woods SP; Ellis RJ; Atkinson JH; Heaton RK; Grant I;
    AIDS Care; 2012; 24(12):1504-13. PubMed ID: 22530794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Depression and neurocognitive performance in Portuguese patients infected with HIV.
    Bragança M; Palha A
    AIDS Behav; 2011 Nov; 15(8):1879-87. PubMed ID: 21598031
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Substance use is a risk factor for neurocognitive deficits and neuropsychiatric distress in acute and early HIV infection.
    Weber E; Morgan EE; Iudicello JE; Blackstone K; Grant I; Ellis RJ; Letendre SL; Little S; Morris S; Smith DM; Moore DJ; Woods SP;
    J Neurovirol; 2013 Feb; 19(1):65-74. PubMed ID: 23250704
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Major depressive disorder, cognitive symptoms, and neuropsychological performance among ethnically diverse HIV+ men and women.
    Fellows RP; Byrd DA; Morgello S;
    J Int Neuropsychol Soc; 2013 Feb; 19(2):216-25. PubMed ID: 23290446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Independent effects of HIV infection and cocaine dependence on neurocognitive impairment in a community sample living in the southern United States.
    Meade CS; Towe SL; Skalski LM; Robertson KR
    Drug Alcohol Depend; 2015 Apr; 149():128-35. PubMed ID: 25697913
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Neurocognitive disorders related to human immunodeficiency virus infection].
    Muñoz-Moreno JA; Blanch Andreu J
    Med Clin (Barc); 2009 May; 132(20):787-91. PubMed ID: 19361818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of human immunodeficiency virus-associated cognitive impairment in a group of Hispanic women at risk for neurological impairment.
    Wojna V; Skolasky RL; Hechavarría R; Mayo R; Selnes O; McArthur JC; Meléndez LM; Maldonado E; Zorrilla CD; García H; Kraiselburd E; Nath A
    J Neurovirol; 2006 Oct; 12(5):356-64. PubMed ID: 17065128
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurocognitive dysfunction in HIV-infected youth: investigating the relationship with immune activation.
    Eckard AR; Rosebush JC; O'Riordan MA; Graves CC; Alexander A; Grover AK; Lee ST; Habib JG; Ruff JH; Chahroudi A; McComsey GA
    Antivir Ther; 2017; 22(8):669-680. PubMed ID: 28327462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlates of sexual activity and sexually transmitted infections among human immunodeficiency virus-infected youth in the LEGACY cohort, United States, 2006.
    Setse RW; Siberry GK; Gravitt PE; Moss WJ; Agwu AL; Wheeling JT; Bohannon BA; Dominguez KL;
    Pediatr Infect Dis J; 2011 Nov; 30(11):967-73. PubMed ID: 22001904
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Role of Behavioral and Neurocognitive Functioning in Substance Use Among Youth with Perinatally Acquired HIV Infection and Perinatal HIV Exposure Without Infection.
    Nichols SL; Brummel S; Malee KM; Mellins CA; Moscicki AB; Smith R; Cuadra AM; Bryant K; Boyce CA; Tassiopoulos KK;
    AIDS Behav; 2021 Sep; 25(9):2827-2840. PubMed ID: 33616833
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Depressive and conduct disorder symptoms in youth living with HIV: the independent and interactive roles of coping and neuropsychological functioning.
    Salama C; Morris M; Armistead L; Koenig LJ; Demas P; Ferdon C; Bachanas P
    AIDS Care; 2013; 25(2):160-8. PubMed ID: 22690655
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors of highly active antiretroviral therapy utilization for behaviorally HIV-1-infected youth: impact of adult versus pediatric clinical care site.
    Agwu AL; Siberry GK; Ellen J; Fleishman JA; Rutstein R; Gaur AH; Korthuis PT; Warford R; Spector SA; Gebo KA
    J Adolesc Health; 2012 May; 50(5):471-7. PubMed ID: 22525110
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Real-world impact of neurocognitive deficits in acute and early HIV infection.
    Doyle KL; Morgan EE; Morris S; Smith DM; Little S; Iudicello JE; Blackstone K; Moore DJ; Grant I; Letendre SL; Woods SP;
    J Neurovirol; 2013 Dec; 19(6):565-73. PubMed ID: 24277439
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and behavioral characteristics of adults receiving medical care for HIV infection --- Medical Monitoring Project, United States, 2007.
    Blair JM; McNaghten AD; Frazier EL; Skarbinski J; Huang P; Heffelfinger JD
    MMWR Surveill Summ; 2011 Sep; 60(11):1-20. PubMed ID: 21881551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.